Vitamin E deficiency
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Lactating women; normal delivery; term delivery; aged 18 to 40 years.
Exclusion criteria
Exclusion criteria: Women with any clinical sign of disease; infections; syphilis; HIV; gastrointestinal diseases; liver disease; heart disease; diabetes; hypertension; cancer; twin pregnancie; newborn with fetal malformations; history of abortion; use of supplements containing vitamin E during pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: Increased secretion of vitamin E in breast milk after supplementation. This outcome is assessed by determining of alpha- tocopherol concentration in human milk before and after supplementation of supplemented groups and verification of variation percentage, and comparing the test groups concentrations with the control group.;Outcome found: Women who received supplementation showed higher concentrations alpha-tocopherol in colostrum than the control group, with 57% and 39% increase in women supplemented with natural and synthetic forms of vitamin E, respectively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome: Greater increased concentration of vitamin E in breast milk of mothers supplemented with alpha-tocopherol in the natural way, when compared to the synthetic form, verified by determining the concentration of this vitamin in milk before and after supplementation of the supplemented groups and comparison of the variation found percentages, and comparing the concentrations of both groups with the control group.;Outcome found: Women who received the natural vitamin E supplementation had on average 49.6% higher concentration of alpha-tocopherol in milk than those who received synthetic capsules. | — |
Countries
Brazil
Contacts
Universidade Federal do Rio Grande do Norte